The fresh attention to alternative and "evidence-based" therapeutic approaches, along with the new questions about the value of lifelong antipsychotic medications for people with schizophrenia, can potentially strengthen the way mental health providers respond to this often-devastating illness.
While it's great that we have modern medicine and pharmacology to alleviate the embarrassing problems of the natural aging process, I'm really much too busy to "grow old gracefully." I can't imagine retiring. That's where the apps come in.
Richard A. Friedman notes in a recent New York Times article that by any standards, atypical antipsychotics are overprescribed. But he leaves out two groups that are especially vulnerable to abuse by these chemical agents: the elderly and children.